Arcadia Biosciences Inc.
| NASDAQ: RKDA | Basic Materials / Agriculture / USA |
| 0.3151 | -0.0053 | -1.65% | Vol 191.27K | 1Y Perf -59.94% |
| Jan 27th, 2023 16:00 DELAYED |
| BID | 0.2900 | ASK | 0.3360 | ||
| Open | 0.3415 | Previous Close | 0.3204 | ||
| Pre-Market | - | After-Market | 0.32 | ||
| - - | 0.00 1.56% |
| Target Price | 3.25 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 931.42 | Finscreener Ranking | ★★★★★ 70.06 | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★★★ 62.04 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★★+ 65.63 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 2.34 | Earnings Rating | Strong Buy | |
| Market Cap | 7.76M | Earnings Date | 10th Nov 2022 | |
| Alpha | 0.06 | Standard Deviation | 0.71 | |
| Beta | 0.04 |
Today's Price Range 0.30000.3415 | 52W Range 0.25902.66 | 5 Year PE Ratio Range -2.40-1.50 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -9.25% | ||
| 1 Month | 20.08% | ||
| 3 Months | -9.97% | ||
| 6 Months | -62.75% | ||
| 1 Year | -59.94% | ||
| 3 Years | -93.72% | ||
| 5 Years | -95.05% | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -59.18 | |||
ROE last 12 Months | -69.41 | |||
ROA (5Y Avg) | -17.76 | |||
ROA last 12 Months | -48.23 | |||
ROC (5Y Avg) | -104.03 | |||
ROC last 12 Months | -57.52 | |||
Return on invested Capital Q | -10.13 | |||
Return on invested Capital Y | -23.79 | |||
Assets Turnover | 0.20 | |||
Receivables Turnover | 4.60 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.40 | ||||
| 0.32 | ||||
| 0.92 | ||||
| - | ||||
| -0.70 | ||||
| -0.80 | ||||
| 0.33 | ||||
| 1.02 | ||||
| -12 368 800.00 | ||||
| Forward PE | -0.52 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 6.30 | ||||
| 7.40 | ||||
| 0.05 | ||||
| 0.09 | ||||
| 15.39K | ||||
| Leverage Ratio | 1.30 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -7.90 | ||||
| -88.50 | ||||
| -83.10 | ||||
| -859.20 | ||||
| 20.09 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 8.96M | ||||
| 0.36 | ||||
| 86.83 | ||||
| 20.88 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q03 2022 | -0.19 | -0.12 | 36.84 |
| Q02 2022 | -0.31 | -0.17 | 45.16 |
| Q01 2022 | -0.31 | -0.21 | 32.26 |
| Q04 2021 | -0.28 | -0.42 | -50.00 |
| Q03 2021 | -0.23 | -0.37 | -60.87 |
| Q02 2021 | -0.23 | -0.26 | -13.04 |
| Q01 2021 | -0.31 | -0.21 | 32.26 |
| Q04 2020 | -0.41 | 0.01 | 102.44 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 12/2022 QR | -0.18 | 0.00 | - |
| 12/2022 FY | -0.74 | 0.00 | - |
| 3/2023 QR | -0.17 | 0.00 | - |
| 12/2023 FY | -0.60 | 0.00 | - |
| Next Report Date | - |
| Estimated EPS Next Report | -0.19 |
| Estimates Count | 1 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 191.27K |
| Shares Outstanding | 24.64K |
| Shares Float | 22.19M |
| Trades Count | 344 |
| Dollar Volume | 60.13K |
| Avg. Volume | 154.12K |
| Avg. Weekly Volume | 132.51K |
| Avg. Monthly Volume | 151.95K |
| Avg. Quarterly Volume | 177.90K |
Arcadia Biosciences Inc. (NASDAQ: RKDA) stock closed at 0.3151 per share at the end of the most recent trading day (a -1.65% change compared to the prior day closing price) with a volume of 191.27K shares and market capitalization of 7.76M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Agriculture industry, Basic Materials sector and employs 61 people. Arcadia Biosciences Inc. CEO is Matthew T. Plavan.
The one-year performance of Arcadia Biosciences Inc. stock is -59.94%, while year-to-date (YTD) performance is 16.27%. RKDA stock has a five-year performance of -95.05%. Its 52-week range is between 0.259 and 2.66, which gives RKDA stock a 52-week price range ratio of 2.34%
Arcadia Biosciences Inc. currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 0.32, a price-to-sale (PS) ratio of 0.92, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -48.23%, a ROC of -57.52% and a ROE of -69.41%. The company’s profit margin is 20.09%, its EBITDA margin is -83.10%, and its revenue ttm is $8.96 Million , which makes it $0.36 revenue per share.
Of the last four earnings reports from Arcadia Biosciences Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.19 for the next earnings report. Arcadia Biosciences Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Arcadia Biosciences Inc. is Strong Buy (1), with a target price of $3.25, which is +931.42% compared to the current price. The earnings rating for Arcadia Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Arcadia Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Arcadia Biosciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.20, ATR14 : 0.04, CCI20 : -27.71, Chaikin Money Flow : -0.20, MACD : 0.00, Money Flow Index : 55.07, ROC : -10.79, RSI : 46.97, STOCH (14,3) : 12.36, STOCH RSI : 0.00, UO : 32.55, Williams %R : -87.64), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Arcadia Biosciences Inc. in the last 12-months were: Pamela Haley (Buy at a value of $490)
Arcadia Biosciences Inc.
Arcadia Biosciences Inc is an agricultural biotechnology trait company. The company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. Geographically, it operates from in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.
CEO: Matthew T. Plavan
Telephone: +1 530 756-7077
Address: 202 Cousteau Place, Davis 95618, CA, US
Number of employees: 61
